| pegylated liposomal doxorubicin / Generic mfg. |
NCT00003334: Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract |
|
|
| Completed | 2 | | US | paclitaxel, pegylated liposomal doxorubicin hydrochloride | NYU Langone Health, National Cancer Institute (NCI) | Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Sarcoma | 12/01 | | | |
NCT00005643: Chemotherapy in Treating Patients With Sarcoma of the Uterus |
|
|
| Completed | 2 | | US, Canada | pegylated liposomal doxorubicin hydrochloride | Gynecologic Oncology Group, National Cancer Institute (NCI) | Endometrial Cancer, Sarcoma | 03/05 | | | |
NCT00005861: Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer |
|
|
| Completed | 2 | | US | pegylated liposomal doxorubicin hydrochloride | Gynecologic Oncology Group, National Cancer Institute (NCI) | Endometrial Cancer | 08/05 | | | |
NCT00470067: Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer |
|
|
| Terminated | 2 | 9 | US | carboplatin, pegylated liposomal doxorubicin hydrochloride | Roswell Park Cancer Institute | Endometrial Cancer | 05/08 | 12/09 | | |
NCT00032162: Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer |
|
|
| Completed | 1/2 | 63 | Europe | carboplatin, pegylated liposomal doxorubicin hydrochloride | AGO Study Group | Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Sarcoma | 05/05 | | | |
